- A study published in 2020 showed that 100% of Red-tailed Hawks that were admitted to the Tufts Wildlife Clinic tested positive for the presence of rodenticides
- Given how rodents remain a crucial food source for birds of prey, anticoagulant rat poison is threatening these populations
- SenesTech, a rodent fertility control product provider, and the inventor of the only EPA-registered contraceptive for male and female rats, offers a much safer alternative
- The company’s Evolve(TM) soft bait products for rats and mice have been scientifically proven to manage rodent infestations, while minimizing risk to human health or the larger environment
- This supports the well-being of birds of prey and other animals while proactively managing rodent pest populations
Back in 2020, a study published by Tufts Wildlife Clinic and Cummings School of Veterinary Medicine showed that 100% of the Red-tailed Hawks admitted into their clinic tested positive for rodenticides. Earlier this year, Flaco, a famous Eurasian eagle owl that lived in Central Park, was found dead. A necropsy would later reveal that he was exposed to four different second-generation anticoagulant rodenticides (“SGARs”). It shed light on the use of rodenticides for rodent population control and its impact beyond rodents and onto a broader ecosystem that includes birds and other animals (https://ibn.fm/m6wJW).
SenesTech (NASDAQ: SNES), a rodent fertility control product provider and inventor of the only EPA-registered contraceptive for male and female rats, has addressed adverse safety and environmental issues of poisons through the use of non-lethal methods of rodent population control. Its flagship product line…
NOTE TO INVESTORS: The latest news and updates relating to SNES are available in the company’s newsroom at https://ibn.fm/SNES
About InvestorWire
InvestorWire (“IW”) is a specialized communications platform with a focus on advanced wire-grade press release syndication for private and public companies and the investment community. It is one of 60+ brands within the Dynamic Brand Portfolio @ IBN that delivers: (1) access to a vast network of wire solutions via InvestorWire to efficiently and effectively reach a myriad of target markets, demographics and diverse industries; (2) article and editorial syndication to 5,000+ outlets; (3) enhanced press release enhancement to ensure maximum impact; (4) social media distribution via IBN to millions of social media followers; and (5) a full array of tailored corporate communications solutions. With broad reach and a seasoned team of contributing journalists and writers, IW is uniquely positioned to best serve private and public companies that want to reach a wide audience of investors, influencers, consumers, journalists and the general public. By cutting through the overload of information in today’s market, IW brings its clients unparalleled recognition and brand awareness. IW is where breaking news, insightful content and actionable information converge.
For more information, please visit https://www.InvestorWire.com
Please see full terms of use and disclaimers on the InvestorWire website applicable to all content provided by IW, wherever published or re-published: https://www.InvestorWire.com/Disclaimer
InvestorWire
Los Angeles, CA
www.InvestorWire.com
310.299.1717 Office
Editor@InvestorWire.com
InvestorWire is powered by IBN
